Clever Culture Systems Limited (CC5.XA)
Cboe AU · AUD
A$0.019 (+5.56%) as of
Key statistics
- 52-week range
- 0.0130 – 0.0330
- Beta
- 1.62
- Revenue (TTM)
- 4.62M
- Profit margin
- -48.45%
- Volume
- 206.19k
About Clever Culture Systems Limited
Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for the medical industry in Australia, the United States, United Kingdom, Germany, Denmark, Australia, Netherlands, Sweden, China, and France. The company offers Automated Plate Assessment System, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; Digital Microbiology; and APAS modules, an artificial intelligence algorithm that works with the APAS Independence to enable digital microbiology culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes urine screening, infection control testing, and antimicrobial susceptibility testing. The company serves global pharmaceutical manufacturers, clinical laboratories, and microbiology labs. The company was formerly known as LBT Innovations Limited and changed its name to Clever Culture Systems Limited in November 2024. Clever Culture Systems Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.
- Headquarters
- Adelaide, SA, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.